DICE Therapeutics, Inc.
DICEDelisted Aug 9, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645569
DICE Therapeutics, Inc. was delisted on Aug 9, 2023; its insiders filed their last Form 4 on Aug 9, 2023; 160 institutions reported holding it in 13F filings for Q2 2023, worth $2.12B in total; Fairfax Financial was the only superinvestor holding it.
Superinvestors holding DICE, Q2 2023
1 superinvestor reports holding DICE Therapeutics, Inc. on Form 13F, worth $6.04M in total. Weight is DICE Therapeutics, Inc.'s share of each 13F portfolio; actions compare shares with Q1 2023.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Fairfax FinancialPrem Watsa | 0.3% | 130,000 | $6.04M | New |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of DICE each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2023
1 superinvestor holding at quarter end